| Irina Pestrikova |
Irina Pestrikova is the founder of Wells Compliance Group, which was founded in 2014. She held the title of Operations Director from 2014 to 2021. Currently, Ms. Pestrikova is the Senior Director-Finance & Secretary at ENDRA Life Sciences, Inc. since 2021. In terms of education, she obtained an undergraduate degree from Izhevsk State Technical University and an MBA from Pepperdine Graziadio Business School. |
| Amy Sitzler |
Presently, Amy Sitzler occupies the position of Vice President-Engineering & Programs at ENDRA Life Sciences, Inc.
She received an undergraduate degree from Indiana University of Pennsylvania and an MBA from Marquette University. |
| Francois Michelon |
Francois Michelon is currently the Chairman, President & Chief Executive Officer at ENDRA Life Sciences, Inc. He previously worked as the Group Director-Global Services at Smith & Nephew plc from 2004 to 2011, and as the Vice President-3i Division Global Marketing at Zimmer Biomet Holdings, Inc. from 2012 to 2014. Mr. Michelon holds an MBA from Carnegie Mellon University and an undergraduate degree from The University of Chicago. |
| Michael Thornton |
Michael Thornton is the founder of Enhanced Vision Systems, Inc. which was founded in 1996. He was the President of the company from 1997 to 2002. Mr. Thornton is also the founder of Volumetrics Medical Corp. Currently, Mr. Thornton is the Chief Technology Officer at ENDRA Life Sciences, Inc. since 2007 and a Member of the American Association of Physicists In Medicine. Previously, he worked as an Executive-in-Residence at Puretech Health LLC, a Principal at Robarts Research Institute, and a Global Product Manager at GE Healthcare, Inc. Mr. Thornton received his undergraduate degree from the University of Toronto and his graduate degree from the University of Western Ontario. |
| Louis J. Basenese |
Louis J. Basenese is the founder of Disruptive Tech Research LLC, which was founded in 2014, where he held the title of Chief Analyst from 2014 to 2022. Currently, he is an Independent Director at ENDRA Life Sciences, Inc. since 2020 and an Investment Director at Wall Street Daily LLC. Mr. Basenese has an undergraduate degree from the University of Florida and an MBA from Crummer Graduate School of Business. |
| Michael John Harsh |
Michael John Harsh is the founder of Terapede Systems, Inc. founded in 2015, where he holds the title of Chief Product Officer. He currently holds multiple positions, including Independent Director at ENDRA Life Sciences, Inc. since 2015, Independent Non-Executive Director at Imagion Biosystems Ltd. since 2017, Director at EmOpti, Inc. since 2015, Advisor at Invenshure LLC, Member at Radiological Society of North America, Inc. since 2017, Trustee at Research & Education Foundation since 2017, Advisor at Magnetic Insight, Inc. since 2015, and Advisor at Tau Ventures LLC. He was also an Advisor at Phoenix LLC from 2015 to 2018. Mr. Harsh received his undergraduate degree from Marquette University in 1978. |
| Alexander Y. Tokman |
Alexander Y. Tokman is an Independent Director at ENDRA Life Sciences, Inc., President & Director at iUNU, Inc., and Independent Director at Izotropic Corp. He is also an Independent Director at American Academy of Thermography. Previously, he served as President, Chief Executive Officer & Director at MicroVision, Inc. from 2006 to 2017. He was also the Chief Executive Officer at The Allen Institute For Artificial Intelligence from 2019 to 2020. Prior to that, he was the GM-Global Molecular Imaging & Radiopharmacy at GE Healthcare Ltd. (United Kingdom) from 2003 to 2005 and Head-Industry & Regional Development at Tracor Applied Sciences, Inc. from 1989 to 1995. He received his undergraduate and graduate degrees from the University of Massachusetts Dartmouth. |
| Anthony DiGiandomenico |
Anthony DiGiandomenico is the founder of Public Ventures LLC, which was founded in 1997. He currently holds director positions at Pier Acquisition I, Inc., Pier Acquisition II, Inc., MDB Capital Holdings LLC, Invizyne Technologies, Inc., and is an independent director at ENDRA Life Sciences, Inc. He previously served as President & CEO of Digian Co., and as a director at Orion Acquisition Corp. II, Charlies Holdings, Inc., Cue Biopharma, Inc., and Provention Bio, Inc. He also served as Managing Director at National Association of Securities Dealers, Inc. from 1997. Mr. DiGiandomenico received his undergraduate degree from The University of Colorado and his MBA from Haas School of Business. |
